BioCentury
ARTICLE | Company News

Dara BioSciences sales and marketing update

October 1, 2012 7:00 AM UTC

Dara said it will launch breast cancer drug Soltamox tamoxifen in the U.S. in mid-October. Dara acquired exclusive, U.S. marketing rights to the product through its January acquisition of Oncogenerix Inc., which licensed the rights from Rosemont Pharmaceuticals Ltd. (Leeds, U.K.) in June 2011(see BioCentury, Jan. 23). ...